Northwest Biotherapeutics: Q2 Earnings Snapshot
In This Article:
BETHESDA, Md. (AP) — BETHESDA, Md. (AP) — Northwest Biotherapeutics Inc. (NWBO) on Friday reported a loss of $17.9 million in its second quarter.
The Bethesda, Maryland-based company said it had a loss of 2 cents per share.
The cancer drug developer posted revenue of $510,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NWBO at https://www.zacks.com/ap/NWBO
Terms and Privacy Policy